164 related articles for article (PubMed ID: 38182638)
1. Identification of therapeutic targets and prognostic biomarkers in the Siglec family of genes in tumor immune microenvironment of sarcoma.
Qi L; Jiang K; Zhao FF; Ren P; Wang L
Sci Rep; 2024 Jan; 14(1):577. PubMed ID: 38182638
[TBL] [Abstract][Full Text] [Related]
2. Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Tan W; Peng S; Li Z; Zhang R; Xiao Y; Chen X; Zhu J; Li B; Lv X
Comput Math Methods Med; 2022; 2022():2021613. PubMed ID: 35069777
[TBL] [Abstract][Full Text] [Related]
3. Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis.
Li B; Zhang B; Wang X; Zeng Z; Huang Z; Zhang L; Wei F; Ren X; Yang L
Oncoimmunology; 2020 Aug; 9(1):1807291. PubMed ID: 32939323
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence.
Cui L; Tian X; Yan L; Guan X; Dong B; Zhao M; Lv A; Liu D; Wu J; Hao C
Int J Med Sci; 2022; 19(13):1977-1988. PubMed ID: 36438917
[No Abstract] [Full Text] [Related]
5. A comprehensive computational analysis to explore the importance of SIGLECs in HCC biology.
Yao S; Chen W; Chen T; Zuo H; Bi Z; Zhang X; Pang L; Jing Y; Yin X; Cheng H
BMC Gastroenterol; 2023 Feb; 23(1):42. PubMed ID: 36803349
[TBL] [Abstract][Full Text] [Related]
6. Siglec Signaling in the Tumor Microenvironment.
van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ
Front Immunol; 2021; 12():790317. PubMed ID: 34966391
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics analysis of Siglec family genes in cutaneous melanoma.
Li K; Xu N; Guo S
Front Immunol; 2023; 14():1036019. PubMed ID: 37207210
[TBL] [Abstract][Full Text] [Related]
8. Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.
Benmerzoug S; Chevalier MF; Verardo M; Nguyen S; Cesson V; Schneider AK; Dartiguenave F; Rodrigues-Dias SC; Lucca I; Jichlinski P; Roth B; Nardelli-Haefliger D; Derré L
Eur Urol Focus; 2022 May; 8(3):748-751. PubMed ID: 34147404
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
Shi H; Gao L; Zhang W; Jiang M
BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
[TBL] [Abstract][Full Text] [Related]
10. Regulation of prognosis-related Siglecs in the glioma microenvironment.
Mao R; Zhou L; Yang Y; Wang P; Lin H; Zheng J; Lv G; Zhou D
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3343-3357. PubMed ID: 34472004
[TBL] [Abstract][Full Text] [Related]
11. Relationships of SIGLEC family-related lncRNAs with clinical prognosis and tumor immune microenvironment in ovarian cancer.
Jin X; Chen Y; Hu Q
Sci Rep; 2024 Mar; 14(1):7593. PubMed ID: 38556590
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of expression, prognosis and immune infiltration of GINS family genes in human sarcoma.
Zhang K; Zhou J; Wu T; Tian Q; Liu T; Wang W; Zhong H; Chen Z; Xiao X; Wu G
Aging (Albany NY); 2022 Jul; 14(14):5895-5907. PubMed ID: 35896011
[TBL] [Abstract][Full Text] [Related]
13. Tumor Derived SIGLEC Family Genes May Play Roles in Tumor Genesis, Progression, and Immune Microenvironment Regulation.
Chen Z; Yu M; Guo L; Zhang B; Liu S; Zhang W; Zhou B; Yan J; Ma Q; Yang Z; Xiao Y; Xu Y; Li H; Ye Q
Front Oncol; 2020; 10():586820. PubMed ID: 33240817
[TBL] [Abstract][Full Text] [Related]
14. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
15. Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma.
Chen Q; Chen B; Wang C; Hu L; Wu Q; Zhu Y; Zhang Q
Front Immunol; 2023; 14():1159085. PubMed ID: 37234161
[TBL] [Abstract][Full Text] [Related]
16. The Pan-Cancer Crosstalk Between the
Xie R; Yuan M; Jiang Y
Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
[No Abstract] [Full Text] [Related]
17. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
18. Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.
Tanida S; Akita K; Ishida A; Mori Y; Toda M; Inoue M; Ohta M; Yashiro M; Sawada T; Hirakawa K; Nakada H
J Biol Chem; 2013 Nov; 288(44):31842-52. PubMed ID: 24045940
[TBL] [Abstract][Full Text] [Related]
19. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
[TBL] [Abstract][Full Text] [Related]
20. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]